Patel Chintu (CIK 1737428) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy AMRX (59,931 shares), Sell AMRX (17,112 shares), Buy AMRX (733,944 shares), Sell AMRX (315,885 shares), Buy AMRX (92,593 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Buy | 59,931 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Sell | 17,112 | $227,761 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Buy | 733,944 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Sell | 315,885 | $4.2M |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Buy | 92,593 | $0 |
| 2026-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Sell | 28,983 | $385,474 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Buy | 579,710 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Sell | 274,307 | $2.4M |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Buy | 92,592 | $0 |
| 2025-03-05 | Amneal Pharmaceuticals, Inc. (AMRX) | Co-CEO | Sell | 46,528 | $411,308 |
Source: SEC Form 4 filings · as of 2026-03-05